Ellerbroek Renee R MD is categorized under Pathological Laboratories in Des Moines, IA and active since 1959.
Ellerbroek Renee R MD was established in 1959, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Renee Ellerbroek at the company’s single location by writing to 1212 Pleasant St # Ll3, Des Moines, Iowa IA 50309 or by phoning (515) 241-8866. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ellerbroek Renee R MD |
| Contact Person: | Renee Ellerbroek |
| Address: | 1212 Pleasant St # Ll3, Des Moines, Iowa 50309 |
| Phone Number: | (515) 241-8866 |
| Website Address: | iowapath.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1959 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6211110 |
| Share This Business: |
Ellerbroek Renee R MD was started in 1959 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Renee Ellerbroek for inquiries that concern Ellerbroek Renee R MD by calling the company number (515) 241-8866, as your correspondence is most welcome. Additionally, the physical location of the single location of Ellerbroek Renee R MD can be found at the coordinates 41.5899,-93.6358 as well as the street address 1212 Pleasant St # Ll3 in Des Moines, Iowa 50309.
For its online presence, you may visit Ellerbroek Renee R MD’s website at iowapath.com and engage with its social media outlets through on Twitter and on Facebook.